封面
市場調查報告書
商品編碼
1794621

全球超音波設備市場

Phacoemulsification Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 278 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球超音波市場規模將達到 27 億美元

全球超音波設備市場規模預計在2024年達到21億美元,預計在2024-2030年的分析期內將以4.3%的複合年成長率成長,到2030年將達到27億美元。超音波乳化白內障吸除耗材是本報告分析的細分市場之一,預計其複合年成長率將達5.1%,到分析期末將達到18億美元。超音波乳化白內障吸除系統細分市場在分析期間的複合年成長率預計為2.8%。

美國市場規模估計為 5.817 億美元,中國市場預計複合年成長率為 8.0%

美國超音波設備市場規模預計2024年達到5.817億美元。作為世界第二大經濟體,中國市場規模預計在2030年達到5.684億美元,2024年至2030年的複合年成長率為8.0%。其他值得關注的區域市場包括日本和加拿大,預計在分析期間的複合年成長率分別為1.7%和3.4%。在歐洲,預計德國市場的複合年成長率為2.5%。

全球超音波市場—主要趨勢與促進因素摘要

為什麼全球對超音波設備的需求不斷成長?

由於白內障盛行率不斷上升,尤其是在老化社會,全球對超音波術設備的需求持續穩定成長。白內障是全球視力障礙和失明的主要原因之一,而超音波吸除術因其微創、恢復快、成功率高,已成為白內障手術的黃金標準。老齡人口的不斷成長,尤其是在北美、歐洲和亞太部分地區,推動了對高效、安全、可靠的白內障治療的需求。各國政府和醫療體係正在大力投資眼科基礎設施,以應對日益加重的患者負擔,尤其是在那些以減少可預防失明為公共衛生任務的國家。此外,患者意識的提升和手術效果的改善,促使超音波乳化白內障吸除術迅速取代傳統的超音波白內障摘除術。現代超音波吸除系統帶來的便利性和精準性,加上新興市場可支配收入的不斷成長和醫療保險覆蓋率的提高,進一步推動了這些先進設備的廣泛應用。此外,慈善和非政府組織主導的舉措在將超音波技術引入服務不足地區、拓寬市場基礎方面發揮關鍵作用。隨著全球繼續關注生活品質和功能壽命,人們對視覺健康的興趣預計將進一步加速。

科技進步如何重新定義眼科手術的精確度?

超音波和抽吸設備的技術創新大大提高了手術精確度、安全性和患者預後。最新設備具有先進的流體系統、即時術中回饋和能量調節功能,可最大限度地減少熱損傷並提高晶狀體摘除效率。向微切口白內障手術 (MICS) 的轉變帶來了對更緊湊、更精密的牙科手機和機器的需求,這些手機和機器可在不影響手術控制的情況下進行更小的切口。扭轉超音波技術、智慧抽吸控制和整合光同調斷層掃瞄(OCT) 等創新徹底改變了白內障手術的實施方式。現在許多系統都提供基於晶狀體硬度、患者眼部解剖結構和外科醫生偏好的可自訂設置,從而最佳化預後並減少併發症。觸控螢幕介面和雲端連接整合支援即時數據追蹤和手術性能分析,增強了手術培訓和標準化。此外,飛秒雷射輔助白內障手術 (FLACS) 的興起,透過提高水晶體碎裂和撕囊的精準度,補充了超音波乳化白內障吸除術和抽吸術。業內公司正大力投入研發,旨在使系統更符合人體工學、節能高效、反應速度更快。這些創新不僅改善了臨床療效,也為新一代外科醫師帶來了設備的易用性。隨著該領域的不斷發展,超音波超音波乳化白內障吸除系統將變得更加智慧、創傷更小,並能根據每例手術的具體需求進行客製化。

醫療保健基礎設施和外科手術培訓在市場滲透中將發揮什麼作用?

超音波系統的廣泛應用在很大程度上取決於熟練眼科醫師的供應和醫療基礎設施的品質。在高所得國家,由於普遍能獲得最先進的手術設備,超音波乳化白內障吸除術幾乎完全取代了超音波摘除術。然而,在許多中低收入國家,由於缺乏訓練有素的外科醫生和設備不足的手術中心,超音波系統的廣泛應用仍然有限。為了彌補這一差距,一些製造商和非營利組織正致力於透過全球推廣計畫開展教育和技能提升。結構化的訓練模組、虛擬實境模擬器和現場手術研討會正在幫助新一代眼科醫生掌握超音波技術。同時,新興國家門診手術中心和私立眼科醫院的激增,也催生了對高品質、具成本效益手術系統的新需求。保險覆蓋範圍和包含白內障手術的政府資助醫療計畫也正在增加患者數量,並鼓勵醫療機構投資於超音波系統。此外,手術通訊協定和認證要求的標準化也促使越來越多的醫院購買先進設備,以達到國際醫療標準。隨著全球白內障失明負擔的日益加重,提升手術能力和臨床醫生的專業技能對於這些技術的廣泛應用至關重要。隨著對醫療保健服務和技能發展的有針對性的投資,許多尚未開發的市場有望加速成長。

推動超音波市場成長的主要動力有哪些?

超音波市場的成長受到多種因素的驅動,這些因素與技術成熟度、人口結構變化以及不斷發展的醫療服務模式有關。關鍵促進因素包括全球人口快速老化,這導致老齡化性白內障盛行率上升,從而增加了對外科手術的需求。同時,設備功能的不斷進步,例如改進的流體動態、即時手術分析和自適應能量輸送系統,正在顯著改善手術效果和患者安全。外科醫師對微創技術和精密器械的日益偏好,進一步鞏固了超音波乳化超音波作為白內障摘除術首選方法的地位。在醫療服務方面,獨立眼科診所、門診手術中心和專科眼科網路的擴張,正在推動對緊湊、便攜和擴充性手術系統的需求。消費者行為也發揮關鍵作用,患者越來越要求更快的康復時間、高清視覺效果和雷射輔助客製化。印度和中國等國政府資助的白內障根除項目,加上西方國家結構化的報銷框架,使得這些先進的系統在經濟上可行且易於普及。此外,選擇性白內障手術的興起以及白內障手術向二級和農村醫療中心的擴展,為器械製造商開闢了新的途徑。最後,全球外科培訓和器材法規的協調一致正在縮短新技術的上市時間,刺激競爭性創新,並增加跨地區更廣泛產品的供應。

部分

產品(超音波耗材、超音波系統);最終用戶(醫院最終用戶、診所最終用戶、研究所最終用戶)

受訪公司範例

  • Alcon
  • Appasamy Associates
  • Bausch+Lomb
  • BEAVER-Visitec International
  • Carl Zeiss Meditec AG
  • DORC Dutch Ophthalmic
  • Ellex Medical Lasers
  • Essilor Instruments
  • Geuder AG
  • Haag-Streit Group
  • Hoya Corporation
  • Johnson & Johnson Vision
  • LIGHTMED Corporation
  • LUMed
  • NIDEK Co., Ltd.
  • Optikon
  • Optos(a Nikon company)
  • Rumex International
  • STAAR Surgical
  • Topcon Corporation

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢,而是建立了一個從世界各地的專家收集的內容庫,其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口(成品和原始設備製造商)情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手,包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP37719

Global Phacoemulsification Devices Market to Reach US$2.7 Billion by 2030

The global market for Phacoemulsification Devices estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Phacoemulsification Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Phacoemulsification Systems segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$581.7 Million While China is Forecast to Grow at 8.0% CAGR

The Phacoemulsification Devices market in the U.S. is estimated at US$581.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$568.4 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Phacoemulsification Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Phacoemulsification Devices Rising Across the Globe?

The global demand for phacoemulsification devices is witnessing a steady surge due to the rising prevalence of cataracts, particularly among the aging population. Cataracts remain one of the leading causes of visual impairment and blindness globally, and phacoemulsification has become the gold standard in cataract surgery due to its minimally invasive nature, faster recovery time, and high success rate. The increasing geriatric demographic, especially in regions like North America, Europe, and parts of Asia-Pacific, has driven the need for efficient, safe, and reliable cataract treatment options. Governments and healthcare systems are investing significantly in ophthalmic care infrastructure to manage the growing patient burden, particularly in countries with public health mandates to reduce preventable blindness. Moreover, increased patient awareness and the accessibility of better surgical outcomes are contributing to the rapid adoption of phacoemulsification over traditional extracapsular cataract extraction methods. The convenience and precision offered by modern phacoemulsification systems, combined with rising disposable incomes and greater availability of health insurance in emerging markets, have further encouraged the uptake of these advanced devices. Additionally, philanthropic and NGO-led initiatives are playing a significant role in bringing phacoemulsification technologies to underserved areas, broadening the market reach. This increased focus on visual health is expected to accelerate further with continued global emphasis on quality of life and functional longevity.

How Are Technological Advancements Redefining Surgical Precision in Ophthalmology?

Technological innovations in phacoemulsification devices are dramatically improving surgical precision, safety, and patient outcomes. Modern devices now come equipped with advanced fluidics systems, real-time intraoperative feedback, and enhanced energy modulation capabilities that minimize thermal damage and improve lens removal efficiency. The shift toward microincision cataract surgery (MICS) has created a demand for more compact and sophisticated handpieces and machines that facilitate smaller incisions without compromising surgical control. Innovations such as torsional ultrasound technology, intelligent aspiration control, and integrated optical coherence tomography (OCT) have transformed how cataract surgeries are performed. Many systems now offer customizable settings based on lens hardness, patient eye anatomy, and surgeon preferences, resulting in optimized outcomes with reduced complications. Integration of touchscreen interfaces and cloud connectivity allows real-time data tracking and surgical performance analysis, which enhances both procedural training and standardization. Furthermore, the rise of femtosecond laser-assisted cataract surgery (FLACS) is complementing phacoemulsification procedures by improving lens fragmentation and capsulotomy precision. Industry players are investing heavily in R&D to make systems more ergonomic, energy-efficient, and responsive. Such innovations not only boost clinical outcomes but also expand the usability of devices to newer surgeon cohorts. As the field continues to evolve, high-tech phacoemulsification systems are poised to become even more intelligent, less invasive, and tailored to individual surgical needs.

What Role Do Healthcare Infrastructure and Surgical Training Play in Market Penetration?

The spread and adoption of phacoemulsification devices are heavily influenced by the availability of skilled ophthalmic surgeons and the robustness of healthcare infrastructure. In high-income countries, where access to state-of-the-art surgical facilities is more common, phacoemulsification has almost entirely replaced older cataract extraction techniques. However, in many low- and middle-income nations, the lack of trained surgeons and under-equipped surgical centers continues to limit the full-scale adoption of phacoemulsification devices. To bridge this gap, several manufacturers and non-profit organizations are focusing on education and skill-building initiatives through global outreach programs. Structured training modules, virtual reality simulators, and live surgical workshops are helping to train a new generation of ophthalmologists in phacoemulsification techniques. At the same time, the proliferation of ambulatory surgical centers and private eye hospitals in emerging economies is creating new demand for high-quality, cost-effective surgical systems. Insurance coverage and government-sponsored health programs that include cataract surgery have also boosted patient volumes, prompting institutions to invest in phacoemulsification systems. Moreover, standardization of surgical protocols and accreditation requirements is encouraging more hospitals to adopt advanced equipment to meet international care benchmarks. As the global burden of cataract-related blindness grows, expanding surgical capacity and clinician expertise will be essential to enabling widespread adoption of these technologies. With targeted investment in healthcare delivery and skills development, many underpenetrated markets are poised for accelerated growth.

What Are the Key Growth Drivers Powering the Phacoemulsification Devices Market?

The growth in the phacoemulsification devices market is driven by several factors related to technological sophistication, changing demographics, and evolving healthcare delivery models. A primary driver is the rapid aging of the global population, which is leading to a higher incidence of age-related cataracts and consequently, a greater need for surgical intervention. In parallel, the continuous advancement of device functionality such as improved fluidics, real-time surgical analytics, and adaptive energy delivery systems has significantly elevated surgical outcomes and patient safety. Increasing surgeon preference for minimally invasive techniques and precision tools has further solidified phacoemulsification as the preferred method of cataract removal. On the healthcare delivery side, the expansion of private eye clinics, outpatient surgical centers, and specialized ophthalmology networks has amplified the demand for compact, portable, and scalable surgical systems. Consumer behavior is also playing a critical role, with patients increasingly seeking faster recovery, high-definition visual outcomes, and laser-assisted customization. Government-funded cataract elimination programs in countries like India and China, as well as structured reimbursement frameworks in Western nations, have provided financial viability and accessibility to these advanced systems. Additionally, the growing volume of elective cataract procedures and the expansion of cataract surgery into secondary and rural healthcare centers are opening new avenues for device manufacturers. Lastly, the global harmonization of surgical training and device regulation is accelerating time-to-market for new technologies, fueling competitive innovation and broader product availability across regions.

SCOPE OF STUDY:

The report analyzes the Phacoemulsification Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Phacoemulsification Consumables, Phacoemulsification Systems); End-Use (Hospitals End-Use, Clinics End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Alcon
  • Appasamy Associates
  • Bausch + Lomb
  • BEAVER-Visitec International
  • Carl Zeiss Meditec AG
  • D.O.R.C. Dutch Ophthalmic
  • Ellex Medical Lasers
  • Essilor Instruments
  • Geuder AG
  • Haag-Streit Group
  • Hoya Corporation
  • Johnson & Johnson Vision
  • LIGHTMED Corporation
  • LUMed
  • NIDEK Co., Ltd.
  • Optikon
  • Optos (a Nikon company)
  • Rumex International
  • STAAR Surgical
  • Topcon Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Phacoemulsification Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Prevalence of Cataracts Propels Demand for Phacoemulsification Devices
    • Aging Population Trends Expand the Addressable Market for Minimally Invasive Eye Surgeries
    • Technological Advancements in Ultrasound Energy Delivery Drive Innovation in Phacoemulsification Systems
    • Improved Fluidics and Real-Time Feedback Mechanisms Strengthen the Business Case for Next-Gen Devices
    • Increased Surgical Volume in Emerging Markets Spurs Demand for Compact and Cost-Effective Systems
    • Shift Toward Day Surgery and Ambulatory Cataract Procedures Throws the Spotlight on Portable and Rapid-Cycle Devices
    • Rising Demand for Precision and Customization Drives Integration of Digital Imaging and AI-Enabled Platforms
    • Healthcare Infrastructure Expansion in Asia-Pacific and Latin America Fuels Equipment Procurement Growth
    • Preference for Single-Use Handpieces and Consumables Generates Recurring Revenue Streams
    • Surge in Demand for Premium Intraocular Lenses (IOLs) Supports Growth in Advanced Phaco Systems
    • Increased Focus on Surgical Safety and Efficiency Throws the Spotlight on Ergonomic and User-Centric Designs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Phacoemulsification Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Phacoemulsification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Phacoemulsification Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Phacoemulsification Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Phacoemulsification Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Phacoemulsification Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Phacoemulsification Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Phacoemulsification Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Phacoemulsification Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Phacoemulsification Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Phacoemulsification Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Phacoemulsification Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Phacoemulsification Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Phacoemulsification Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Phacoemulsification Devices by Product - Phacoemulsification Consumables and Phacoemulsification Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Phacoemulsification Devices by Product - Percentage Breakdown of Value Sales for Phacoemulsification Consumables and Phacoemulsification Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Phacoemulsification Devices by End-Use - Hospitals End-Use, Clinics End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Phacoemulsification Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Research Institutes End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION